Chaitanya Nirodi
Associate Professor
Oncologic Sciences
Mitchell Cancer Institute
United States of America
Biography
Dr.Chaitanya Nirodi is currently working as Associate Professor at Department of Oncologic Sciences, Mitchell Cancer Institute (USA). He has received his Bachelors in Science from University of Poona, India. Dr. Chaitanya Nirodi has received his Ph.D. in Biochemistry from Indian Institute of Science, India. Dr. Chaitanya Nirodi has many reviewed publications.
Research Interest
To understand mechanisms underlying tumor resistance to ionizing radiation in non-small cell lung carcinoma (NSCLC)
Publications
-
Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264. 7 cells. Proceedings of the National Academy of Sciences. 2004 Feb 17;101(7):1840-5.
-
Das AK, Chen BP, Story MD, Sato M, Minna JD, Chen DJ, Nirodi CS. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non–small cell lung carcinoma. Cancer research. 2007 Jun 1;67(11):5267-74.
-
Chen DJ, Nirodi CS. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clinical Cancer Research. 2007 Nov 15;13(22):6555-60.
-
Das AK, Sato M, Story MD, Peyton M, Graves R, Redpath S, Girard L, Gazdar AF, Shay JW, Minna JD, Nirodi CS. Non–small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer research. 2006 Oct 1;66(19):9601-8.
